Financial Ratios

TTK HEALTHCARE LTD.

NSE : TTKHLTCAREBSE : 507747ISIN CODE : INE910C01018Industry : Pharmaceuticals & DrugsHouse : TTK
BSE1483.059.05 (+0.61 %)
PREV CLOSE ( ) 1474.00
OPEN PRICE ( ) 1486.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 51
TODAY'S LOW / HIGH ( )1481.10 1510.15
52 WK LOW / HIGH ( )1006.05 1681
NSE1476.451.35 (+0.09 %)
PREV CLOSE( ) 1475.10
OPEN PRICE ( ) 1484.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1476.45 (25)
VOLUME 3655
TODAY'S LOW / HIGH( ) 1468.00 1508.65
52 WK LOW / HIGH ( )1012.25 1699
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)31.6113.1026.038.7217.25
   CEPS(Rs)40.6722.0135.2418.8927.63
   DPS(Rs)10.0010.006.003.005.00
   Book NAV/Share(Rs)671.59230.16205.40173.09174.81
   Tax Rate(%)27.5325.47-62.6036.5837.92
Margin Ratios
   Core EBITDA Margin(%)4.323.644.064.387.89
   EBIT Margin(%)9.224.695.113.516.79
   Pre Tax Margin(%)8.504.144.753.016.25
   PAT Margin (%)6.163.097.731.913.88
   Cash Profit Margin (%)7.935.1910.464.136.22
Performance Ratios
   ROA(%)5.203.568.042.945.99
   ROE(%)7.016.0213.765.0110.25
   ROCE(%)10.138.598.388.2815.46
   Asset Turnover(x)0.841.151.041.541.54
   Sales/Fixed Asset(x)4.413.703.104.414.40
   Working Capital/Sales(x)0.852.662.555.105.48
Efficiency Ratios
   Fixed Capital/Sales(x)0.230.270.320.230.23
   Receivable days36.6734.5252.3544.3739.41
   Inventory Days41.1445.4554.4235.8831.45
   Payable days119.60130.35160.52111.76110.54
Valuation Parameters
   PER(x)32.7163.2919.0037.5039.34
   PCE(x)25.4237.6814.0317.3124.56
   Price/Book(x)1.543.602.411.893.88
   Yield(%)0.971.211.210.920.74
   EV/Net Sales(x)0.881.531.030.551.37
   EV/Core EBITDA(x)8.0324.0616.719.6615.04
   EV/EBIT(x)9.5632.7120.0915.7820.21
   EV/CE(x)0.551.671.000.842.10
   M Cap / Sales2.011.961.470.721.53
Growth Ratio
   Net Sales Growth(%)21.0125.88-26.282.858.72
   Core EBITDA Growth(%)108.7630.47-21.08-35.3114.34
   EBIT Growth(%)138.2015.387.22-46.7822.26
   PAT Growth(%)141.32-49.68198.57-49.4634.18
   EPS Growth(%)141.31-49.68198.57-49.4634.18
Financial Stability Ratios
   Total Debt/Equity(x)0.030.060.060.120.12
   Current Ratio(x)5.062.131.991.741.73
   Quick Ratio(x)4.661.741.621.321.38
   Interest Cover(x)12.768.6714.226.9412.62
   Total Debt/Mcap(x)0.020.020.030.060.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.